Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Recent progress in superantigen research]

K Tomonari1

  • 1Department of Immunology and Parasitology, Fukui Medical School.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Involvement of brown adipose tissue in subcutaneous fat necrosis of the newborn.

Dermatology (Basel, Switzerland)·2011
Same author

Root of the small-bowel mesentery: correlative anatomy and CT features of pathologic conditions.

Radiographics : a review publication of the Radiological Society of North America, Inc·2001
Same author

An immature rat lymphocyte marker CD157: striking differences in the expression between mice and rats.

Immunobiology·2001
Same author

Leiomyoma of the parapharyngeal space.

Radiation medicine·1999
Same author

A new mouse lymphocyte antigen encoded by a gene in the Nk complex.

Immunogenetics·1999
Same author

Pelvic extension of retroperitoneal fluid: analysis in vivo.

AJR. American journal of roentgenology·1998
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Significant advancements in superantigen research in 1993 clarified mouse mammary tumor virus (MMTV) life cycles and elucidated toxic shock syndrome toxin 1 structure. Future applications in autoimmunity and cancer therapies are anticipated.

Area of Science:

  • Immunology
  • Virology
  • Structural Biology

Context:

  • Superantigens are potent immune activators implicated in various diseases.
  • Research in 1993 focused on understanding their mechanisms and origins.
  • Mouse mammary tumor viruses (MMTV) and toxic shock syndrome toxin 1 were key areas of investigation.

Purpose:

  • To summarize key advancements in superantigen research during 1993.
  • To highlight the elucidation of MMTV (SW) life cycle and toxic shock syndrome toxin 1 structure.
  • To identify outstanding questions and future therapeutic potential of superantigens.

Summary:

  • Progress included defining the MMTV (SW) life cycle and completing X-ray crystallography for toxic shock syndrome toxin 1.
  • The role of endogenous Mtv-51 superantigen in B cell lymphoma development in SJL mice was demonstrated.

Related Experiment Videos

  • Unanswered questions remain regarding human endogenous superantigens, their role in autoimmunity, and MMTV superantigen structures.
  • Impact:

    • Established a clearer understanding of superantigen biology and their viral origins.
    • Provided structural insights into a key superantigen involved in toxic shock syndrome.
    • Laid the groundwork for future research into superantigen-related diseases and therapeutic strategies for autoimmunity and cancer.